Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H19N3 |
Molecular Weight | 265.3529 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
InChI
InChIKey=RONZAEMNMFQXRA-UHFFFAOYSA-N
InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3
Molecular Formula | C17H19N3 |
Molecular Weight | 265.3529 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:19:27 UTC 2023
by
admin
on
Sat Dec 16 17:19:27 UTC 2023
|
Record UNII |
A051Q2099Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548216
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
||
|
WHO-ATC |
N06AX11
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
||
|
WHO-VATC |
QN06AX11
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
85650-52-8
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
7241
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
DB00370
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
6481
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
15996
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | RxNorm | ||
|
6950
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
DTXSID0023325
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
288-060-6
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
4205
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
1444279
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
Mirtazapine
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
MIRTAZAPINE
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
m7561
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL654
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
SUB08996MIG
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
Z-13
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
1816
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
C035133
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
A051Q2099Q
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
100000091441
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
C29265
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY | |||
|
61337-67-5
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
SUPERSEDED | |||
|
A051Q2099Q
Created by
admin on Sat Dec 16 17:19:30 UTC 2023 , Edited by admin on Sat Dec 16 17:19:30 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
TARGET -> AGONIST |
SHORT-ACTING
|
||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
|
||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE -> PARENT |
IN-VIVO
Scientific Literature
|
||
|
METABOLITE -> PARENT |
IN-VIVO
Scientific Literature
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
NOAEL | TOXICITY |
|
|
|||